Sale Date Set for Amgen's Biosimilar of Humira

Amgen Inc.’s Amjevita, a biosimilar of the bestselling drug in the world, will launch in Europe and the United States in 2018 and 2023, respectively, the company announced.

Amgen Partnership Takes Biosimilars to China

Amgen Inc. on Tuesday announced an exclusive agreement with Simcere Pharmaceutical Group to co-develop and commercialize four biosimilar drugs in China.

Lab Closure Means Layoffs for 55 Workers

Providence Saint Joseph Medical Center will lay off approximately 55 people in late October, according to a notice provided to the state’s Employment Development Department.

Amgen Reaffirms Guidance After Hurricane Maria

Amgen Inc. does not anticipate interruptions in its drug supply caused by Hurricane Maria and affirmed its guidance for the year, the company announced Monday.

Biotech Execs Foresee Industry's Critical Mass in Region

Biotech startup executives discussed the industry’s challenges and opportunities in the Valley region during the Corporate Leaders Breakfast organized by California Lutheran University on Friday at the Ronald Reagan Presidential Library in Simi Valley.

FDA Approves Amgen Cancer Treatment Mvasi

The U.S. Food and Drug Administration announced it has approved Amgen Inc.’s biosimilar drug Mvasi for treatment of multiple types of cancer. It is the first biosimilar approved in the U.S. for cancer.

Providence St. Joseph Reorganizes SoCal Operations

Providence St. Joseph Health announced today that Erik Wexler will lead the combined hospital network of Providence Health & Services in Los Angeles, Orange and San Bernardino counties.

MannKind Completes HQ Relocation to Westlake Village

MannKind Corp. on Tuesday announced that it has completed the relocation of its corporate headquarters to Westlake Village. The biotech company was formally headquartered in Mann Biomedical Park in Valencia.

Tease photo

Henry Mayo Newhall Hospital Names Chief Info Officer

Henry Mayo Newhall Hospital on Tuesday announced the appointment of Ray Moss as vice president and chief information officer.

FDA Approves Trials for Second Sight's New Prosthetic Eye

Second Sight Medical Products Inc. on Monday announced that it has received approval from the U.S. Food and Drug Administration to begin a human clinical study for its latest visual prosthesis system, Orion.

Amgen Expands Science Education Program

Amgen Inc. on Thursday announced its foundation will expand the Amgen Biotech Experience program to nine new markets worldwide.

Hilton Foundation Gives $2 Million to Bangladesh Research Group

The Conrad N. Hilton Foundation has awarded its $2 million Hilton Humanitarian Prize to International Center for Diarrheal Disease Control, Bangladesh, or iccdr,b, an international research institute focused on improving public health in developing countries.

Fitness Franchisee Takes Over Thousand Oaks Bay Club

The Thousand Oaks Bay Club, a luxury athletic club that is part of a chain of country clubs in California, has been taken over by a local sports and fitness franchisee.

Atara Biotherapeutics Hires Chief Medical Officer

Atara Biotherapeutics Inc. announced Tuesday the hiring of Dr. Kanya Rajangam as senior vice president and chief medical officer.

HemaCare Turns Profitable in First Half of 2017

HemaCare Corp. announced Monday a 50 percent increase in revenue and a swing from losses to profits during the first six month of the year.